During the past decade, Fundacion Hospital Universidad del Norte conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 2 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 2 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fundacion Hospital Universidad del Norte" #1 sponsor was "Actelion" with 2 trials, followed by "Janssen Research & Development, LLC" with 2 trials sponsored, "Genova Inc." with 1 trials sponsored, "Janssen Vaccines & Prevention B.V." with 1 trials sponsored and "R-Pharm International, LLC" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fundacion Hospital Universidad del Norte" #1 collaborator was "Mene Research" with 1 trials as a collaborator, "OCT Clinical Trials" with 1 trials as a collaborator and "Quintiles, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Fundacion Hospital Universidad del Norte" are "Acute Respiratory Infection" (1 trials), "Covid19" (1 trials), "Dengue" (1 trials), "Hypertension, Pulmonary" (1 trials) and "Lennox Gastaut Syndrome" (1 trials). Many other conditions were trialed in "Fundacion Hospital Universidad del Norte" in a lesser frequency.

Most popular intervention types in "Fundacion Hospital Universidad del Norte" are "Drug" (5 trials), "Biological" (2 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Ad26.COV2.S" (1 trials), "Carisbamate" (1 trials), "JNJ-64281802" (1 trials) and "Macitentan 10 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fundacion Hospital Universidad del Norte" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Fundacion Hospital Universidad del Norte". undefined are not yet recruiting, 6 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Fundacion Hospital Universidad del Norte, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Fundacion Hospital Universidad del Norte, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".